The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary

Publisher: Bentham Science Publishers

E-ISSN: 1875-6557 |4|4|293-299

ISSN: 1573-403x

Source: Current Cardiology Reviews, Vol.4, Iss.4, 2008-11, pp. : 293-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract